SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950144-03-001926
Filing Date
2003-02-14
Accepted
2003-02-14 14:59:07
Documents
2
Group Members
PHARMABIO DEVELOPMENT INC.

Document Format Files

Seq Description Document Type Size
1 DISCOVERY LABORATORIES, INC. g80689dsc13gza.htm SC 13G/A 29482
3 JOINT FILING AGREEMENT BETWEEN QUINTILES, PHARMA g80689dexv1.htm EX-1 6022
  Complete submission text file 0000950144-03-001926.txt   38031
Mailing Address 4709 CREEKSTONE DR STE 300 DURHAM NC 27703-8411
Business Address 4709 CREEKSTONE DR RIVERBIRCH BLDG STE 200 DURHAM NC 27703-8411 9199982000
QUINTILES TRANSNATIONAL CORP (Filed by) CIK: 0000919623 (see all company filings)

IRS No.: 561714315 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901
Business Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901 2152404699
DISCOVERY LABORATORIES INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48466 | Film No.: 03566741
SIC: 2836 Biological Products, (No Diagnostic Substances)